Synergistic Effects of Medium-chain and Omega-3 Triglycerides on Cellular Omega-3 Fatty Acid Enrichment: Characterization, Mechanisms, and Optimization
中链甘油三酯和 Omega-3 甘油三酯对细胞 Omega-3 脂肪酸富集的协同效应:表征、机制和优化
基本信息
- 批准号:10538572
- 负责人:
- 金额:$ 38.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-10 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcuteAddressAffectAnimal ModelAnti-Inflammatory AgentsAntiinflammatory EffectApoptosisApoptoticAreaBioenergeticsBiophysicsBlood PlateletsBolus InfusionBrain DeathCell DeathCell Membrane StructuresCell SeparationCell membraneCell modelCellsCellular StructuresCerebral IschemiaChronicClinicalCoupledDataDimensionsDiseaseDocosahexaenoic AcidsEicosanoidsEicosapentaenoic AcidEmulsionsEndothelial CellsExperimental Animal ModelFatty AcidsFish OilsFishesFree RadicalsFunctional disorderHomeostasisHydrolysisHydrophobicityImmuneImmune responseIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjectionsIntakeIntravenousIntravenous BolusIntravenous infusion proceduresIschemic StrokeLaboratoriesLeukocytesLipidsLiquid substanceMacrophageMass Spectrum AnalysisMediatingMedium chain triglyceridesMembraneMembrane LipidsMetabolicMethodsModelingMolecular ConformationMonoclonal AntibodiesMorbidity - disease rateMyocardial InfarctionNon-Steroidal Anti-Inflammatory AgentsNuclear Magnetic ResonanceOilsOmega-3 Fatty AcidsOperative Surgical ProceduresOralOrganParenteral NutritionPathway interactionsPhospholipidsPhysical ChemistryPhysiologicalPlasmaPreventionProductionPropertyRegulationReportingResearchResolutionRouteSeriesSpinal cord injuryStimulusSystemTNF geneTherapeuticTherapeutic AgentsTissuesTriglyceride MetabolismTriglyceridesacute infectionadvanced analyticsbiophysical propertiesbiophysical techniquesdesignexperimental studyfatty acid oxidationhealinghuman modelin vivoinnovationintravenous injectionlipid disorderlipid metabolismlipidomicslipophilicitymembrane activitymembrane modelmonocytemouse modelmultidisciplinarynovelnovel therapeutic interventionoptical imagingorgan injuryparticlepost strokepreservationpreventresponsesynergismsystemic inflammatory responsetissue injuryuptake
项目摘要
Adverse inflammatory response leads to cell death and organ dysfunction. We will investigate whether acute intravenous (IV) treatments of lipid emulsions containing medium-chain triglycerides (TG) (MCT) and omega-3 (n-3) TG enriched in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) provide a new therapeutic approach to ameliorate adverse inflammatory responses by targeting rapid cellular n-3 FA membrane enrichment. n-3 fatty acids (FA) are increasingly recognized as a potent supplement in IV feeding because of their pro-healing and anti-inflammatory effects against apoptosis and production of free radicals and pro- inflammatory eicosanoids. Studies in experimental animal models demonstrate that bolus injections of n-3 TG- rich emulsion particles (TGRP) are therapeutically protective in decreasing brain death and morbidity after stroke. We have discovered that TGRP containing both MCT and fish oil TG (8:2 wt/wt) enriched cell membranes of white blood cells and endothelial cells with n-3 FA more efficiently than other TGRP. Using nuclear magnetic resonance (NMR), we reported that the inclusion of MCT into model TGRP promotes model membrane lipid disorder that may accelerate n-3 delivery rates, highlighting the advantage of bolus injection for n-3 FA enrichment. However, very few studies have addressed the acute anti-inflammatory effects of acute IV n-3 administration. Currently, there is no data on optimal mixtures of MCT with n-3 TG to achieve the most rapid and highest-magnitude anti-inflammatory action. Our central hypothesis is that bolus injections of TGRPs containing both MCT and n-3 TG will cooperatively affect membrane dynamics to accelerate n-3 FA incorporation into cell membranes, which will initiate n-3-mediated anti-inflammatory and anti-apoptotic actions. These will be studied under 3 Specific Aims. Under Aim 1, we will characterize biophysical properties of MCT-containing TGRP with different n-3 TG contents using biophysical approaches coupled with mass spectrometry-based lipidomics to assess alteration in membrane structure and activity mediated by specific MCT:n-3 TGRP containing DHA, EPA, or both. In Aim 2, we will define cellular uptake pathways responsible for internalization and metabolic utilization of specific MCT:n-3 TGRP characterized in Aim 1 in cultured immune-effector macrophages and in mouse models. We will then investigate under Aim 3 how MCT:n-3 TGRP cellular internalization affects functional activities of monocytes and macrophages in response to an acute immune stimulus (LPS) in mouse models. The proposed studies in cells and animal models will establish innovative methods that are adaptable for targeted, rapid delivery of lipophilic and hydrophobic therapeutic agents to specific organs or tissues. We will uncover novel synergies between MCT and n-3 TG that modulate membrane lipid composition, cell lipid metabolism, and immune responses. Our studies will be of high significance to many fields, including immune responses to infection and inflammation-related tissue injury and organ dysfunction.
不良炎症反应导致细胞死亡和器官功能障碍。我们将研究含有富含二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)的中链甘油三酯(TG)(MCT)和omega-3(n-3)TG的脂肪乳剂的急性静脉(IV)治疗是否提供了一种新的治疗方法,通过靶向快速细胞n-3 FA膜富集来改善不良炎症反应。n-3脂肪酸(FA)由于其对细胞凋亡和自由基及促炎性类二十烷酸的产生的促愈合和抗炎作用而日益被认为是IV喂养中的有效补充剂。在实验动物模型中的研究表明,n-3富含TG的乳剂颗粒(TGRP)的推注在减少中风后的脑死亡和发病率方面具有治疗保护作用。我们已经发现,含有MCT和鱼油TG(8:2 wt/wt)的TGRP比其他TGRP更有效地富集具有n-3 FA的白色血细胞和内皮细胞的细胞膜。使用核磁共振(NMR),我们报告称,将MCT纳入模型TGRP可促进模型膜脂质紊乱,这可能会加速n-3递送速率,突出了推注用于n-3 FA富集的优势。然而,很少有研究涉及急性IV n-3给药的急性抗炎作用。目前,没有关于MCT与n-3 TG的最佳混合物以实现最快速和最高强度抗炎作用的数据。我们的中心假设是,包含MCT和n-3 TG的TGRP的推注将协同影响膜动力学,以加速n-3 FA掺入细胞膜,这将启动n-3介导的抗炎和抗凋亡作用。这些将在三个具体目标下进行研究。在目标1下,我们将使用生物物理方法结合基于质谱的脂质组学来表征具有不同n-3 TG含量的含MCT的TGRP的生物物理特性,以评估由含DHA、EPA或两者的特定MCT:n-3 TGRP介导的膜结构和活性的改变。在目标2中,我们将在培养的免疫效应巨噬细胞和小鼠模型中定义负责目标1中表征的特异性MCT:n-3 TGRP内化和代谢利用的细胞摄取途径。然后,我们将在目标3下研究MCT:n-3 TGRP细胞内化如何影响小鼠模型中单核细胞和巨噬细胞对急性免疫刺激(LPS)的功能活性。拟议的细胞和动物模型研究将建立创新方法,适用于将亲脂性和疏水性治疗剂靶向快速递送至特定器官或组织。我们将揭示MCT和n-3 TG之间的新型协同作用,调节膜脂质组成,细胞脂质代谢和免疫反应。我们的研究将对许多领域具有重要意义,包括感染和炎症相关的组织损伤和器官功能障碍的免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chuchun Liz Chang其他文献
Chuchun Liz Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chuchun Liz Chang', 18)}}的其他基金
Synergistic Effects of Medium-chain and Omega-3 Triglycerides on Cellular Omega-3 Fatty Acid Enrichment: Characterization, Mechanisms, and Optimization
中链甘油三酯和 Omega-3 甘油三酯对细胞 Omega-3 脂肪酸富集的协同效应:表征、机制和优化
- 批准号:
10319563 - 财政年份:2020
- 资助金额:
$ 38.59万 - 项目类别:
Synergistic Effects of Medium-chain and Omega-3 Triglycerides on Cellular Omega-3 Fatty Acid Enrichment: Characterization, Mechanisms, and Optimization
中链甘油三酯和 Omega-3 甘油三酯对细胞 Omega-3 脂肪酸富集的协同效应:表征、机制和优化
- 批准号:
9885786 - 财政年份:2020
- 资助金额:
$ 38.59万 - 项目类别:
Synergistic Effects of Medium-chain and Omega-3 Triglycerides on Cellular Omega-3 Fatty Acid Enrichment: Characterization, Mechanisms, and Optimization
中链甘油三酯和 Omega-3 甘油三酯对细胞 Omega-3 脂肪酸富集的协同效应:表征、机制和优化
- 批准号:
10376531 - 财政年份:2020
- 资助金额:
$ 38.59万 - 项目类别:
Synergistic Effects of Medium-chain and Omega-3 Triglycerides on Cellular Omega-3 Fatty Acid Enrichment: Characterization, Mechanisms, and Optimization
中链甘油三酯和 Omega-3 甘油三酯对细胞 Omega-3 脂肪酸富集的协同效应:表征、机制和优化
- 批准号:
10084291 - 财政年份:2020
- 资助金额:
$ 38.59万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 38.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 38.59万 - 项目类别:
Operating Grants